Marks Group Wealth Management Inc Reduces Stake in Haleon plc (NYSE:HLN)

Marks Group Wealth Management Inc cut its stake in Haleon plc (NYSE:HLN) by 38.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 93,607 shares of the company’s stock after selling 58,131 shares during the quarter. Marks Group Wealth Management Inc’s holdings in Haleon were worth $893,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Lake Street Advisors Group LLC increased its position in Haleon by 5.4% during the third quarter. Lake Street Advisors Group LLC now owns 22,395 shares of the company’s stock worth $237,000 after purchasing an additional 1,143 shares during the last quarter. Synovus Financial Corp increased its holdings in shares of Haleon by 0.8% during the 3rd quarter. Synovus Financial Corp now owns 148,834 shares of the company’s stock worth $1,575,000 after buying an additional 1,216 shares during the last quarter. Greenleaf Trust increased its holdings in shares of Haleon by 8.4% during the 4th quarter. Greenleaf Trust now owns 17,225 shares of the company’s stock worth $164,000 after buying an additional 1,333 shares during the last quarter. Baron Wealth Management LLC raised its position in shares of Haleon by 4.3% during the 4th quarter. Baron Wealth Management LLC now owns 33,632 shares of the company’s stock valued at $321,000 after buying an additional 1,381 shares during the period. Finally, Peapack Gladstone Financial Corp lifted its holdings in Haleon by 3.2% in the third quarter. Peapack Gladstone Financial Corp now owns 44,844 shares of the company’s stock valued at $474,000 after acquiring an additional 1,390 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE HLN opened at $9.85 on Thursday. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.44. The business’s 50 day moving average is $9.53 and its two-hundred day moving average is $9.79. Haleon plc has a 52-week low of $7.89 and a 52-week high of $10.80. The firm has a market cap of $44.59 billion, a price-to-earnings ratio of 28.97, a PEG ratio of 2.70 and a beta of 0.28.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on HLN shares. Morgan Stanley downgraded Haleon from an “overweight” rating to an “equal weight” rating in a research report on Friday, January 10th. Sanford C. Bernstein lowered shares of Haleon from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 8th. Three analysts have rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $10.95.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.